Japan Tissue Engineering Co., Ltd.
Japan Tissue Engineering Co., Ltd. (JPX: 7774) is trading at ¥848.00, about ₹516 at today's JPY/INR rate, as of 25 Sep 2026, 2:30 AM ET, down 1.17% today. Indian residents can buy Japan Tissue Engineering from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
¥833.00
Today's high
¥865.00
52 week low
¥448.00
52 week high
¥927.00
7774 opened at ¥865.00, closed previously at ¥858.00, and has traded between ¥448.00 and ¥927.00 over the past 52 weeks.
About
Japan Tissue Engineering Co., Ltd. operates within the regenerative medicine sector in Japan. The company's activities are organized into three core divisions: Regenerative Medicine Product, Regenerative Medicine Outsourcing, and Research and Development Support. It manufactures and delivers autologous cultured tissues, such as epidermis, cartilage, corneal epithelium, and oral mucosal epithelium, to medical institutions for therapeutic applications. The firm also produces other advanced tissue-engineered medical products. Furthermore, Japan Tissue Engineering is involved in the research and development of three-dimensional human cultured tissue models, which are utilized in the development of external-use cosmetics and drugs, as well as for scientific investigations concerning skin and corneal tissues. Additionally, the company provides comprehensive contract development and manufacturing services for regenerative medicine. Established in 1999, Japan Tissue Engineering Co., Ltd. is based in Gamagori, Japan, and functions as a subsidiary of Teijin Limited.
Key statistics
Avg. volume
98.53K
Market cap
¥34.44B
P/E Ratio
-78.23
Price-to-sales ratio
13.65
Enterprise value
¥31.09B
Free cash flow yield
0.00%
Debt-to-equity ratio
0.00
Return on equity
-8.40%
ROIC
-4.75%
Beta
1.08
Dividend yield
0.00%
Last dividend
¥0.00
Financial overview
Revenue
¥2.18B
Earnings per share
-¥18.09
Free cash flow
-¥562.67M
Net profit margin
-17.44%
Gross margin
61.96%
EBITDA
-¥392.06M
Revenue growth
-11.11%
Similar securities
This is not an investment recommendation
How to buy Japan Tissue Engineering from India
Indian residents can buy Japan Tissue Engineering shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to JPY.
Search for Japan Tissue Engineering and place an order
Find Japan Tissue Engineering by name or by its ticker, 7774, and choose an order type. The Tokyo Stock Exchange typically trades in units of 100 shares. Japan Tissue Engineering trades 5:30 am – 12:00 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Japan Tissue Engineering position in JPY and INR. Japan Tissue Engineering pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in Japan Tissue Engineering from India
Trading and taxes when buying Japan Tissue Engineering from India
Trading and limits
- Trading hours
- 9:00 am – 3:30 pm JST
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneJapan Tissue Engineering does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
- Estate or inheritance tax
- May applyJapan levies inheritance tax on Japan-located assets such as direct stocks, with an exemption of ¥30 million plus ¥6 million per statutory heir.Estate tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy Japan Tissue Engineering stock?
Yes. Japan Tissue Engineering (7774) has been listed on the Tokyo Stock Exchange since 2007, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to JPY. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one Japan Tissue Engineering share cost in rupees?
One Japan Tissue Engineering share is ¥848.00 — about ₹516 at a JPY/INR rate of 0.6089 on 25 Sep 2026. Both the Japan Tissue Engineering price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Japan Tissue Engineering from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
What is the minimum I can buy of Japan Tissue Engineering?
The Tokyo Stock Exchange typically trades in units of 100 shares.
How are gains on Japan Tissue Engineering shares taxed in India?
Japan generally does not levy capital gains tax on non-resident individual investors, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the JPY/INR rate on the purchase and the sale date, so the rupee move counts alongside the Japan Tissue Engineering price. Paasa issues a capital-gains statement for your return.
Does Japan Tissue Engineering pay a dividend?
No. Japan Tissue Engineering does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade Japan Tissue Engineering from India?
The Tokyo Stock Exchange trades 5:30 am – 12:00 pm IST in Indian time. It also halts for lunch, 8:00 am – 9:00 am IST. Orders can only execute during that window.
Is there estate or inheritance tax on Japan Tissue Engineering shares held from India?
Japan levies inheritance tax on Japan-located assets such as direct stocks, with an exemption of ¥30 million plus ¥6 million per statutory heir. It applies to your overall holdings in that jurisdiction rather than to any one position.
Do I have to declare Japan Tissue Engineering shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Japan Tissue Engineering holding, its cost and its closing value.
How do I sell Japan Tissue Engineering and bring the money back to India?
You sell during market hours (5:30 am – 12:00 pm IST) and the proceeds settle in JPY in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.